The LTM pathway, which regulates immune cell trafficking across the endothelial barrier, is disrupted in HPV-positive cervical cancer due to the reduced expression of key genes such as HSPA5, CTNNB1, and NPM1. The gene discussed is CTNNB1; the disease is cervical carcinoma.